Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1997-12-15
1999-11-09
Fan, Jane
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514414, A61K 3144
Patent
active
059815531
ABSTRACT:
The present invention is new 3-(heterocyclic)-propenoic acid derivatives and pharmaceutical compositions thereof. These new 3-(heterocyclic)-propenoic acid derivatives are useful as NMDA antagonist.
REFERENCES:
patent: 5106847 (1992-04-01), Salituro et al.
patent: 5519048 (1996-05-01), Salituro et al.
patent: 5714500 (1998-02-01), Griffith et al.
Salituro F.G. et al, Bioorganic & Medicinal Chem. Ltrs, vol. 1, No. 9 pp. 455-460, 1991.
Kemp, John A., TiPS--Jan. 1993, vol. 14, No. 1, pp. 20-25.
Schelkun, R.M. et Al, 33rd Nat'l Organic Chemistry Symposium Bozeman, MT--Jun., 1993 Abstract #B-73.
Thornber, Chemical Society Review, vol. 8, No. 4, 1979.
Farr Robert
Harrison Boyd
Nyce Philip
Fan Jane
Ferrell Michael W.
Hoechst Marion Roussel Inc.
LandOfFree
Heterocycle substituted propenoic acid derivatives as NMDA antag does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Heterocycle substituted propenoic acid derivatives as NMDA antag, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Heterocycle substituted propenoic acid derivatives as NMDA antag will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1456460